miR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2
Chunliang Xu(China Electronics Technology Group Corporation), Yufang Shi(Soochow University), Pengfei Yu(University of Illinois Urbana-Champaign), Wei Cao(Shanghai Jiao Tong University), Xiaoyan Han(Hebei Medical University), Liangyu Lin(Shanghai Jiao Tong University), Peishun Shou(University of North Carolina at Chapel Hill), Gary Brewer(Rutgers, The State University of New Jersey), Qing Chen(Integrated Chinese Medicine (China)), Qian Yang(Shanghai Jiao Tong University), Menghui Jiang(Qingdao University), Guan Wang(First Hospital of China Medical University), Chunxing Zheng(Hong Kong Science and Technology Parks Corporation), Gang Cao(Nanjing University of Chinese Medicine), Ying Wang(State Ethnic Affairs Commission), Liming Du(Wenzhou Medical University), Xin Zhang(Hefei University), Guangwen Ren(Jackson Laboratory)
Cited by 92
Related Papers
Mesenchymal stem cells: a new trend for cell therapy
|Acta Pharmacologica Sinica|2013|947
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair
|Cell Research|2010|574
Mesenchymal stem cells: a double-edged sword in regulating immune responses
|Cell Death and Differentiation|2012|434
A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1
|Cell Research|2008|388
Immunomodulatory properties of stem cells from human exfoliated deciduous teeth
|Stem Cell Research & Therapy|2010|382